ProQR Therapeutics N.V. (PRQR) Balance Sheet

NASDAQ: PRQRAssets, liabilities, debt and equity over 10 years.

PRQR balance sheet, 2025

December 31, 2025 · euros

€132.4M assets = €74.4M liabilities + €58.0M equity

What it owns€132.4MCash & ST investments: €108.5M (82.0%)Cash & ST investments€108.5M · 82%Receivables: €6.0M (4.5%)Other current: €3.1M (2.3%)PP&E: €14.8M (11.2%)PP&E €14.8MOther non-current: €1 (0.0%)=How it is financed€132.4MCurrent liabilities: €38.1M (28.8%)Current liabilities€38.1M · 29%Other LT liabilities: €36.3M (27.4%)Other LT liabilities€36.3M · 27%Shareholders’ equity: €58.0M (43.8%)Shareholders’ equity€58.0M · 44%

Both columns are drawn to the same scale: what PRQR owns equals what it owes plus shareholders’ equity. Hover a block for its value.

PRQR financial health

Current ratio3.09
Comfortable · current assets cover current liabilities 3.09×
Debt / equity0.28
Low leverage · €0.28 of debt for each $1 of equity
Equity / assets43.8%
Equity-funded · of assets funded by shareholders
Cash / debt660.5%
Cash covers debt · cash & short-term investments vs total debt
Goodwill & intangibles0.0%
Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal 2025.

PRQR balance sheet trends, 2016–2025

MetricTrendThenLatestChange
Total assets€69.1M2016€132.4M2025+7.5%/yr
Total liabilities€13.1M2016€74.4M2025+21.3%/yr
Shareholders’ equity€56.0M2016€58.0M2025+0.4%/yr
Cash & short-term investments€62.4M2016€108.5M2025+6.3%/yr
Total debt€4.8M2016€16.4M2025+14.5%/yr
Net cash (debt)€57.6M2016€92.1M2025+€34.5M
Working capital€58.3M2016€79.5M2025+€21.2M
Current ratio9.2420163.092025−6.16
Debt / equity0.0920160.282025+0.20
Shares outstanding23.3M2016105.3M2025+18.2%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

PRQR assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

PRQR liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

PRQR debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

PRQR balance sheet in euros

2025202420232022202120202019201820172016
Assets
Cash & short-term investments€108.5M€154.7M€131.4M€101.1M€213.3M€92.8M€125.7M€105.6M€57.8M€62.4M
Cash & equivalents€108.5M€154.7M€131.4M€101.1M€213.3M€92.8M€125.7M€105.6M€57.8M€62.4M
Short-term investments——−€98,050———€0€0€0€0
Receivables€6.0M€2.1M€1.4M€61.1M€935,915€978,840€1.3M€1.2M€563,175€1.7M
Inventory€0€0€1€6,865€266,455€379,000€340,000€899,000€73,000€1.2M
Other current assets€3.1M€2.5M€875,986€2.6M€3.3M€3.8M€1.4M€645,000€2.3M€148,438
Total current assets€117.6M€159.3M€133.6M€164.8M€217.8M€97.9M€128.7M€108.4M€60.7M€65.4M
Property, plant & equipment (net)€14.8M€14.6M€18.7M€17.3M€19.9M€22.8M€2.7M€1.9M€3.0M€3.6M
Goodwill & intangible assets€0€0€0€0€0€0€0€0€46,831€94,927
Long-term investments€0€0€0€621,000€629,000€107,000€429,000€0€0€0
Other non-current assets€1€1€0€41,762€86,299€23,920€52,553€0€0€1
Total assets€132.4M€173.9M€152.3M€182.8M€238.3M€120.8M€131.9M€110.2M€63.8M€69.1M
Liabilities
Accounts payable€349,986€16,568€1.7M€418,362€217,205€270,404€499,512€135,000€655,636€345,958
Short-term debt€5.2M€4.6M€1.8M€4.1M€7.2M€2.9M€955,247€7,000€2.4M€0
Deferred revenue€20.6M€22.7M€22.7M€6.0M€5.8M€856,485€798,097€545,000€416,677—
Total current liabilities€38.1M€40.3M€37.8M€22.4M€31.4M€12.6M€12.3M€8.2M€10.2M€7.1M
Long-term debt€0€0€4.3M€4.3M€39.3M€16.2M€12.7M€28.1M€5.3M€5.7M
Lease obligations€11.1M€12.6M€15.4M€15.2M€16.3M€17.0M€508,000€0€0€0
Other long-term liabilities€36.3M€41.9M€64.5M€85.0M€38.9M€22.8M€1.6M€0€1.1M€311,910
Total liabilities€74.4M€82.2M€106.6M€111.7M€109.6M€51.6M€26.6M€17.5M€16.5M€13.1M
Shareholders' equity
Common stock & paid-in capital€5.1M€4.5M€3.7M€3.6M€3.4M€2.6M€2.4M€1.7M€1.7M€985,136
Retained earnings (deficit)−€549.1M−€442.3M−€442.8M−€404.6M−€361.4M−€315.4M−€237.7M−€155.4M−€143.3M−€79.9M
Treasury stock——————€0€0€0€0
Accumulated other comprehensive income€33.7M€28.6M€28.7M€32.3M€34.5M€29.3M€18.7M€108,000€10.2M€4.6M
Minority interest€0€0€0−€384,000——€0€0€0€0
Total shareholders' equity€58.0M€91.7M€45.7M€71.6M€129.5M€69.9M€105.9M€92.7M€47.3M€56.0M
Key figures
Total debt€16.4M€16.1M€21.8M€23.4M€68.7M€41.9M€15.2M€28.1M€8.7M€4.8M
Net cash (debt)€92.1M€138.6M€109.6M€77.7M€144.6M€50.9M€110.4M€77.4M€49.1M€57.6M
Working capital€79.5M€119.0M€95.9M€142.4M€186.4M€85.3M€116.4M€100.2M€50.5M€58.3M
Tangible book value€58.0M€91.7M€45.7M€71.6M€129.5M€69.9M€105.9M€92.7M€47.2M€56.0M
Shares outstanding105.3M81.7M81.0M71.6M64.2M50.1M41.0M34.1M25.4M23.3M
Current ratio3.093.953.547.366.947.7710.4313.285.959.24
Quick ratio3.013.893.517.246.837.4410.2913.095.729.06
Debt / equity0.280.180.480.330.530.600.140.300.180.09
Equity / assets43.8%52.7%30.0%39.1%54.3%57.8%80.3%84.1%74.1%81.1%

Quarterly columns are labeled by the month the quarter ended. Figures in euros as reported (latest annual report filed March 12, 2026); data from EODHD.

PRQR financial position

At the end of fiscal 2025 (December 31, 2025), ProQR Therapeutics had total assets of €132.4 million (down 23.9% from a year earlier), total liabilities of €74.4 million and shareholders' equity of €58.0 million. It held €108.5 million in cash and short-term investments against €16.4 million of debt, a net cash position of €92.1 million. Its current ratio was 3.09. In the latest quarter (ended June 30, 2026) total assets were €133.5 million and equity €79.4 million.

Related: PRQR income statement, PRQR cash flow statement, PRQR key metrics. See the PRQR stock overview for the latest quote and news.

PRQR balance sheet FAQ

What are ProQR Therapeutics's total assets?

ProQR Therapeutics reported total assets of €132.4 million at the end of fiscal 2025 (December 31, 2025), compared with €173.9 million a year earlier.

How much debt does ProQR Therapeutics have?

ProQR Therapeutics had €16.4 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.28.

How much cash does ProQR Therapeutics have?

ProQR Therapeutics held €108.5 million in cash and short-term investments at the end of fiscal 2025; with €16.4 million of debt that is net cash of €92.1 million.

What is ProQR Therapeutics's book value?

ProQR Therapeutics's shareholders' equity (book value) was €58.0 million at the end of fiscal 2025.

What is ProQR Therapeutics's current ratio?

ProQR Therapeutics had current assets of €117.6 million and current liabilities of €38.1 million, a current ratio of 3.09 (it can cover its short-term obligations).

Biotechnology: balance sheet